| Primary |
| Attention Deficit/hyperactivity Disorder |
83.5% |
| Psychomotor Hyperactivity |
2.0% |
| Sleep Disorder |
2.0% |
| Bipolar Disorder |
1.6% |
| Hypersensitivity |
1.6% |
| Asperger's Disorder |
1.2% |
| Depression |
1.2% |
| Impulsive Behaviour |
1.2% |
| Aggression |
0.8% |
| Drug Use For Unknown Indication |
0.8% |
| Oppositional Defiant Disorder |
0.8% |
| Abnormal Behaviour |
0.4% |
| Adhd |
0.4% |
| Affective Disorder |
0.4% |
| Anxiety |
0.4% |
| Asthma |
0.4% |
| Autism Spectrum Disorder |
0.4% |
| Bipolar I Disorder |
0.4% |
| Crohn's Disease |
0.4% |
| Developmental Delay |
0.4% |
|
| Convulsion |
11.3% |
| Hallucination |
9.2% |
| Suicidal Ideation |
7.8% |
| Weight Decreased |
7.1% |
| Psychomotor Hyperactivity |
6.4% |
| Depression |
5.7% |
| Psychotic Disorder |
5.7% |
| Visual Acuity Reduced |
5.7% |
| Drug Ineffective |
4.3% |
| Hypertension |
4.3% |
| Vomiting |
4.3% |
| Hallucination, Auditory |
3.5% |
| Speech Disorder |
3.5% |
| Tachycardia |
3.5% |
| Tremor |
3.5% |
| Hallucination, Visual |
2.8% |
| Raynaud's Phenomenon |
2.8% |
| Social Avoidant Behaviour |
2.8% |
| Stevens-johnson Syndrome |
2.8% |
| Visual Disturbance |
2.8% |
|
| Secondary |
| Attention Deficit/hyperactivity Disorder |
66.1% |
| Foetal Exposure During Pregnancy |
4.7% |
| Anxiety |
3.1% |
| Bipolar Disorder |
3.1% |
| Migraine |
3.1% |
| Hypersensitivity |
2.4% |
| Aggression |
1.6% |
| Autism |
1.6% |
| Depression |
1.6% |
| Developmental Delay |
1.6% |
| Dyspepsia |
1.6% |
| Oppositional Defiant Disorder |
1.6% |
| Psychomotor Hyperactivity |
1.6% |
| Speech Disorder Developmental |
1.6% |
| Asperger's Disorder |
0.8% |
| Asthma |
0.8% |
| Crohn's Disease |
0.8% |
| Drug Use For Unknown Indication |
0.8% |
| Gastrooesophageal Reflux Disease |
0.8% |
| Sleep Disorder |
0.8% |
|
| Weight Decreased |
14.9% |
| Visual Acuity Reduced |
9.0% |
| Psychomotor Hyperactivity |
7.5% |
| Bronchitis |
6.0% |
| Decreased Appetite |
6.0% |
| Sleep Disorder |
6.0% |
| Crying |
4.5% |
| Depressed Mood |
4.5% |
| Drug Withdrawal Syndrome |
4.5% |
| Hallucination |
4.5% |
| Hypertension |
4.5% |
| Staring |
4.5% |
| Asthenia |
3.0% |
| Breast Enlargement |
3.0% |
| Cognitive Disorder |
3.0% |
| Drug Effect Decreased |
3.0% |
| Exposure During Pregnancy |
3.0% |
| Mitochondrial Cytopathy |
3.0% |
| Pharmaceutical Product Complaint |
3.0% |
| Raynaud's Phenomenon |
3.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
20.9% |
| Attention Deficit/hyperactivity Disorder |
17.3% |
| Blood Pressure |
8.6% |
| Depression |
8.6% |
| Astrocytoma |
6.5% |
| Tuberous Sclerosis |
6.5% |
| Convulsion |
4.3% |
| Prophylaxis |
4.3% |
| Anxiety |
3.6% |
| Bipolar Disorder |
3.6% |
| Multiple Sclerosis |
2.9% |
| Autism Spectrum Disorder |
1.4% |
| Disturbance In Attention |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Growth Retardation |
1.4% |
| Insomnia |
1.4% |
| Nausea |
1.4% |
| Oppositional Defiant Disorder |
1.4% |
| Pain |
1.4% |
| Product Used For Unknown Indication |
1.4% |
|
| Cough |
11.1% |
| Atrioventricular Block First Degree |
8.3% |
| Convulsion |
5.6% |
| Drug Dispensing Error |
5.6% |
| Dyspepsia |
5.6% |
| Headache |
5.6% |
| Hypersensitivity |
5.6% |
| Neutrophil Count Decreased |
5.6% |
| Tardive Dyskinesia |
5.6% |
| Visual Acuity Reduced |
5.6% |
| Vomiting |
5.6% |
| Weight Decreased |
5.6% |
| Weight Increased |
5.6% |
| Acute Respiratory Failure |
2.8% |
| Aggression |
2.8% |
| Anaphylactic Reaction |
2.8% |
| Atonic Seizures |
2.8% |
| Diabetic Ketoacidosis |
2.8% |
| Disinhibition |
2.8% |
| Disorientation |
2.8% |
|
